MEDIPHARM ANDERLECHT: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIPHARM ANDERLECHT
Largest movements
- Receivables within one year +€34,573
up €34,573 (+81.7%), from €42,336 to €76,909
of which Trade receivables: +€22,208
- Intangible fixed assets -€6,000
down €6,000 (-11.5%), from €52,088 to €46,088
- Stocks and contracts -€3,717
down €3,717 (-5.1%), from €73,187 to €69,470
- Profit (loss) carried forward +€32,003
up €32,003, from -€17,025 to €14,978
- Trade debts -€27,317
down €27,317 (-21.9%), from €124,791 to €97,474
- Other debts +€21,823
up €21,823 (+18.6%), from €117,359 to €139,182
- Tax, wage and social debts -€4,174
down €4,174 (-16.1%), from €25,926 to €21,752
of which Taxes: -€6,653
- Gross operating margin +€78,385
up €78,385 (+59.4%), from €132,033 to €210,418
- Staff costs +€13,091
up €13,091 (+8.6%), from €152,113 to €165,204
- Taxes +€2,792
new in 2025: €2,792
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €262,417 | €285,622 | +€23,205 | +8.8% |
| Fixed assets | 21/28 | €52,088 | €46,088 | -€6,000 | -11.5% |
| Intangible fixed assets | 21 | €52,088 | €46,088 | -€6,000 | -11.5% |
| Current assets | 29/58 | €210,329 | €239,534 | +€29,205 | +13.9% |
| Stocks and contracts in progress | 3 | €73,187 | €69,470 | -€3,717 | -5.1% |
| Stocks | 30/36 | €73,187 | €69,470 | -€3,717 | -5.1% |
| Amounts receivable within one year | 40/41 | €42,336 | €76,909 | +€34,573 | +81.7% |
| Trade receivables | 40 | €32,294 | €54,502 | +€22,208 | +68.8% |
| Other amounts receivable | 41 | €10,043 | €22,408 | +€12,365 | +123.1% |
| Cash at bank and in hand | 54/58 | €58,578 | €56,927 | -€1,651 | -2.8% |
| Deferred charges and accrued income | 490/1 | €36,227 | €36,227 | = | 0.0% |
| Total equity and liabilities | 10/49 | €262,417 | €285,622 | +€23,205 | +8.8% |
| Equity | 10/15 | -€14,025 | €17,978 | +€32,003 | |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€17,025 | €14,978 | +€32,003 | |
| Amounts payable | 17/49 | €276,442 | €267,644 | -€8,798 | -3.2% |
| Amounts payable within one year | 42/48 | €276,442 | €267,644 | -€8,798 | -3.2% |
| Current portion of amounts payable after more than one year | 42 | €8,366 | €9,236 | +€870 | +10.4% |
| Trade debts | 44 | €124,791 | €97,474 | -€27,317 | -21.9% |
| Suppliers | 440/4 | €124,791 | €97,474 | -€27,317 | -21.9% |
| Taxes, remuneration and social security | 45 | €25,926 | €21,752 | -€4,174 | -16.1% |
| Taxes | 450/3 | €8,281 | €1,628 | -€6,653 | -80.3% |
| Remuneration and social security | 454/9 | €17,645 | €20,124 | +€2,478 | +14.0% |
| Other amounts payable | 47/48 | €117,359 | €139,182 | +€21,823 | +18.6% |
| Remuneration, social security and pensions | 62 | €152,113 | €165,204 | +€13,091 | +8.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,224 | €6,000 | -€224 | -3.6% |
| Other operating charges | 640/8 | €2,761 | €2,254 | -€507 | -18.4% |
| Gross operating margin | 9900 | €132,033 | €210,418 | +€78,385 | +59.4% |
| Operating profit (loss) | 9901 | -€29,066 | €36,960 | +€66,025 | |
| Financial income | 75/76B | €4 | €3 | -€2 | -34.6% |
| Recurring financial income | 75 | €4 | €3 | -€2 | -34.6% |
| Financial charges | 65/66B | €2,308 | €2,167 | -€141 | -6.1% |
| Recurring financial charges | 65 | €2,308 | €2,167 | -€141 | -6.1% |
| Profit (loss) for the period before taxes | 9903 | -€31,369 | €34,796 | +€66,165 | |
| Income taxes | 67/77 | - | €2,792 | +€2,792 | |
| Profit (loss) for the period | 9904 | -€31,369 | €32,003 | +€63,373 | |
| Profit (loss) for the period to be appropriated | 9905 | -€31,369 | €32,003 | +€63,373 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.